Jane (or John) Doe was charged with having stolen midazolam, butorphanol and promethazine hydrochloride from their practice for use other than for veterinary purposes, making false clinical records concerning the use of drugs on their own dogs to disguise the fact that the drugs were instead being used for non-veterinary uses, and drawing up medication taken from the practice into a syringe for the purpose of self-medicating.
In addition, they were charged that their conduct was dishonest.
The Committee found it proven that Jane/John Doe had taken approximately 150 vials of midazolam, 87 ampoules, 112 tablets and one elixir bottle of promethazine hydrocholoride, and 0.2mls of butorphanol together with Iml of midazolam for their dog at a time when their dog was, in fact, dead.
The Committee also found it proven that the defendant had drawn up medication for the purpose of self-medicating, and had created false clinical records.
In deciding the sanction, the Committee concluded that the respondent had abused their position of trust, that their actions were dishonest, prolonged and repeated in nature, and undermined the reputation of the profession as a whole.
Therefore the only appropriate action was removal from the Register.
Unusually, the RCVS did not issue a press release about this case, as it normally does.
There was also a protracted delay between the hearing and the report of the hearing being published on the College website.
Furthermore, when it was finally published, the report had been redacted to remove any reference to the name, gender or location of the respondent.
When asked why, the College said: "Matters of a highly confidential nature arose following the hearing which led to a delay in the decisions being published.
“The decisions have been redacted and we cannot provide the reasons for the redactions as that would necessarily involve disclosure of confidential and personal information.
"However, the circumstances are considered to be exceptional and the College’s decision to make the redactions was only made following very careful consideration of evidence provided to the RCVS.
"The decision has been published on the RCVS website in its redacted form and in view of the timeframe and the circumstances, it has not been considered appropriate to issue a press release.”
CommentThe College will for sure have had very good reasons for redacting the name of the respondent in this case.
One has to assume there must have been a very real threat to the respondent’s life, and under those circumstances, confidentiality is absolutely right and proper.
However, whatever the reason, secrecy is never a good look, especially when it comes in the form of a cape worn by a regulator.
So it is frustrating to hear that the College has again made a rod for its own back, when it could so easily have included a very general one-line explanation for why it felt redaction was necessary, without compromising the individual’s confidentiality.
It would have been enough, for example, just to say that the College felt there was a risk to life. People would accept that.
The paper, ‘Mortality Related to General Anaesthesia and Sedation in Dogs under UK Primary Veterinary Care’, published in Veterinary Anaesthesia and Analgesia1, used data from more than 150,000 dogs attending first opinion veterinary practices around the UK.
The study examined the overall risk of death for each dog which had at least one sedation and/or anaesthesia procedure over a set period of time.
The study also looked at anaesthesia related to neutering (spaying and castration) in dogs because these procedures are so common in the UK and anaesthetic risk can be a significant worry for owners.
The findings showed that currently there are 14 deaths in 10,000 dogs within two weeks of sedation/anaesthesia procedures carried out for any reason, of which 10 deaths per 10,000 are within 48 hours of these procedures.
For neutering surgeries in dogs, the risk is even smaller, with one death in 10,000 neuter procedures related to sedation and/or anaesthesia.
No association was seen between the age of puppies at the time of neutering and risk of death.
Factors associated with increased risk of sedation and anaesthetic-related death in this study included:
Certain breeds, such as Cocker Spaniels, were found to be at lower risk compared with mixed breeds.
The team also investigated whether flat-faced ‘brachycephalic’ breeds were associated with higher risk.
Surprisingly, longer-nosed ‘dolichocephalic’ breeds showed four times the odds of sedative/anaesthetic-related death compared with medium-length nose dogs, whereas no additional risk was seen in flat-faced breeds.
The authors of the paper say that overall, these results should provide some reassurance for the veterinary and dog-owning communities regarding the safety of neutering for young puppies, as well as the relative safety of sedatives and anaesthetics for more complex procedures.
For older dogs, those with poorer health or undergoing planned complex surgeries, the results emphasise the value of careful planning to manage the anaesthetic risks.
Urgent procedures, regardless of complexity, were shown to carry greater risk and therefore should be approached with high vigilance and caution.
Dr Dan O’Neill, Associate Professor in Companion Animal Epidemiology at the RVC and co-author of the paper, said:
“This new VetCompass study can help owners deal with these fears by understanding the real anaesthetic risk is not that high: 14 deaths in every 10,000 dogs. Decision-making based on the known can now replace fear of the unknown.”
Full paper: https://doi.org/10.1016/j.vaa.2022.03.006 / https://www.sciencedirect.com/science/article/pii/S1467298722001015
Reference
The Department for Environment, Food and Rural Affairs (Defra) says this is evidence that its strategy to tackle bovine TB, which costs taxpayers £100m a year, is delivering results.
Defra says that gaining OTF status for the low risk area, covering the north and east of England, would boost trade opportunities and mean some herds require less regular TB testing, reducing costs for farmers.
This would be the first time anywhere in England has enjoyed this status and the government says it is a key step in its 25-year plan for the whole of the UK to be TB-free by 2038.
Environment Secretary Andrea Leadsom said: "Gaining global recognition that more than half of England is TB-free will be a significant milestone in our long-term plan to eradicate this devastating disease, and will open up new trading opportunities for farmers.
"We have much still to do in the worst affected parts of the country, but this shows that our strategy - combining practical biosecurity measures, a robust cattle movement and testing regime, and badger control in areas where the disease is rife - is right and is working."
Results published today confirm all ten licensed badger control operations achieved successful outcomes. A consultation opens today on next steps for badger control in areas that have completed the first four years of intensive culling.
Other measures announced today include:
Chief Veterinary Officer Nigel Gibbens said: "This year we have seen that badger control can be delivered successfully on a wider scale. Further expansion in the coming years, alongside our robust cattle movement and testing regime, will allow us to achieve and maintain long term reductions in the level of TB across the South West and Midlands where the disease is currently widespread."
The government says it is taking robust action to make the country TB-free by 2038, with a strategy including stronger cattle testing and movement controls, good biosecurity, badger control in areas where TB is rife and vaccination when possible.
Vaccinating healthy badgers is part of the government’s long-term plan and could play an important role in preventing bovine TB spreading to new areas of the country. Defra plans to resume the Badger Edge Vaccination Scheme, which offers support for private badger vaccination projects in edge area counties, in 2018 when we expect vaccine supplies to be available once more following the current global shortage.
The government is also supporting farmers to take practical action to reduce the risk of infection onto their farm. This includes support for a new CHeCS TB cattle herd accreditation scheme, on-farm biosecurity demonstrations for farmers, and training for veterinary surgeons delivered by APHA jointly with the private sector. Farmers can also access practical guidance on the TB Hub, which brings advice from farming experts, vets and government together in one place.
The charity says that the survey is the largest, most comprehensive insight into pet wellbeing in the UK; an opportunity for veterinary professionals to share their views on the issues affecting the health and welfare of UK pets today.
Vicki Betton, PDSA Policy and Campaigns manager, said: "For the last five years, the PAW Report has provided valuable insight into the reality of pet health and wellbeing in the UK.
"It delivers a robust evidence base for our education programmes, campaigns and collaborative work, and enables us to track our impact on the pet wellbeing issues which are of most concern to the veterinary profession. It also provides an excellent opportunity for everyone to voice their opinions and have their say.
"In 2015, two of the main concerns identified were lack of public understanding of the cost of pet ownership, and a lack of pre-purchase education relating to suitable pet choice. This was reinforced in our survey of pet owners, in which over 95% of pet owners incorrectly estimated the lifetime costs for their pet. As a result, we launched our #PawsFirst campaign to engage pet owners about how to choose the right pet for their lifestyle, while raising awareness of the lifetime costs of different species."
The current survey closes on 4 July. Vicki added: "It only takes 15 minutes, so please help us maintain an accurate picture of the biggest welfare issues facing pets in the UK today."
Take the survey at www.yougov.com/PDSA and help spread the word by sharing on social media - #PAWreport
The veterinary recruitment company Gardner Llewelyn has announced that it is to hold Thank A Vet Nurse Day on 28th May 2015.
As the name suggests the company is urging everyone to join them and make a point of thanking a veterinary nurse on the day for all their dedication and hard work.
In the run up, the company is also asking everyone to think about nominating a veterinary nurse who has gone the extra mile for an award. Two winners will each be given an iPad mini.
You can nominate a nurse here: http://www.glvets.com/competition-entry.asp
Somerset vet Stewart Halperin MRCVS has launched CarefreeCredit, a service designed to help pet owners pay for unforeseen veterinary bills, and take the burden of unpaid bills away from veterinary surgeons.
The new service is very simple. First, participating practices need to apply to CarefreeCredit and register with the Financial Conduct Authority (FCA). CarefreeCredit will hold your hand through the FCA registration process, which is currently taking about three weeks.
Thereafter, you can then offer CarefreeCredit to any client who is faced with an unexpected bill which they can't pay immediately. They'll need to make an online application which can be done at any time of day, 365 days a year - crucial for out-of-hours emergencies. The application takes 4 minutes and decisions are instant.
Loans repaid over 12 months are interest-free for the pet owner. Loans repaid over 24 months attract interest at 7.9% APR.
Once the loan is approved, confirmation is sent to the veterinary practice, which can then drawdown the funds into the practice bank account via the CarefreeCredit online dashboard. The practice gets paid within 5 days of requesting a drawdown.
The cost to the practice of all this is 7% of the bill. Offered strategically to the right clients, that seems like a small price to pay. According to CarefreeCredit, practice revenue increases by 22% and debtors decrease by 58% in practices where finance facilities are offered. But that is, of course, only half the story. This also offers a professional and businesslike 'way out' when vets are at the receiving end of emotional blackmail (or worse) from clients who find they don't have the money to pay for their much-loved pet to get the medical care it needs.
Stewart, himself the owner of a six-practice business, said: "The only way a credit facility like this works is that if it is so simple to use that front office staff see it as a help rather than a hindrance - a tool to make their lives easier rather than just another piece of admin to do. In order to get to this point, we have been through discussions with a number of consumer credit institutions as well as major retail banks. The system we can now provide is the market leader by a long way. The great thing is, vets love it as they can do gold standard work, get paid properly for it and receive the funds straight away. Owners love it as they can spread the cost at no or very low cost to themselves - and of course, the pets get treated immediately!"
For more information, visit: www.carefreecredit.co.uk
Virbac has launched Prinovox, a new prescription-only spot-on ectoparasiticide for dogs and cats.
The company says the new product contains the same combination of Moxidectin and Imidacloprid as the market leader, but is offered with a unique and innovative pet owner engagement programme to help practices build loyalty, increase compliance and to encourage repeat purchase.
In dogs Prinovox is licensed for the treatment and prevention of lungworm; for the treatment and prevention of fleas and also for lice, mites, heartworm and roundworms. In cats, the licence covers fleas, mites, roundworm and heart worm. It can also be used for fleas and heartworm in ferrets.
Prinovox is available in six presentations to suit all weight ranges and in packs of four pipettes. The packaging uses the Blippar platform which owners can use to 'blip' interactive icons on the product's packaging with their smartphone to get more information on Prinovox, including a video on how to use it, a reminder system and a game.
In addition, the Prinovox support package includes:
Virbac's Head of Marketing Companion Animal, Simon Boulton MRCVS said: "We see the launch of Prinovox as a gamechanger. The ectoparasiticide market is one of the largest and most competitive in our industry and we are the first company to offer a product with the same efficacy as the market leader for all indications.
"We've gone one step further by increasing the value of the product to practices by developing a comprehensive parasite protection support package which harnesses the latest technology and consumer preferences for receiving information. We believe the efficacy of Prinovox, combined with the innovative support package we're offering, will make it a highly attractive product for practices and owners and we've been delighted at the feedback we've received so far."
Vet Futures, the joint initiative by the RCVS and the BVA to help the profession prepare for and shape its own future, has published a guest blog in which an academic argues that the profession needs to introduce safeguards to prevent inappropriate profit-seeking behaviour.
David Main is Professor of Animal Welfare at the School of Veterinary Sciences at the University of Bristol, with research interests in welfare assessment, animal welfare education and intervention strategies to improve welfare.
In his blog (www.vetfutures.org.uk/discuss), Professor Main says he believes the vast majority of individual veterinary surgeons and practices are not motivated by money and do have animals’ best interests at heart, but that the differences between the business structure of veterinary and medical practitioners in the UK means the profession is always at risk of standing accused of excessive profiteering.
He said: “Since we still live in the age of the media scare story, it would seem prudent for the profession to embed some anti-profit seeking safeguards in our regulatory controls before, rather than after, a problem is highlighted.” One suggestion he makes is for the prohibition of turnover-based incentive schemes in favour of incentives based on health outcomes.
He believes that such safeguards, which he says could be incorporated into the RCVS Practice Standards Scheme, would be a “healthy demonstration” that the profession has animal welfare rather than profit as its main priority.
Professor Main also argues that the profession urgently needs to deliver on society’s expectation of vets as animal welfare experts: “Veterinarians could perhaps... do more at an individual level to act as animal welfare advocates. It is easy to inform clients on the technical rationale for a specific husbandry change but then walk away knowing full well the client will not action the advice. In the medical profession, advanced communication techniques are becoming more widely accepted to promote positive change within their patients. Perhaps we should be more explicit in teaching our veterinary students influencing skills.”
In response to David’s blog, this month’s Vet Futures poll asks visitors ‘Do vets always act as animal welfare advocates?’
The previous month’s poll, which was based on an article co-written by Erwin Hohn and Adi Nell from MediVet, asked to what extent vets would be willing to work collaboratively with others if it would benefit all. Of the 50 people who answered the poll, 60% said they would be completely willing to work with others, 32% a lot and 8% to some degree – no one said they would be unwilling to work with others.
Henry Schein Inc. has announced an agreement to acquire RxWorks Inc., the veterinary practice management software provider.
Founded in 1988 and with headquarters in Brisbane, Queensland, Australia, RxWorks has 68 team members and an installed base of more than 1,500 veterinary clinics in 19 countries worldwide (primarily Australia, New Zealand, the UK and the Netherlands).
Henry Schein says RxWorks will become part of it's Global Animal Health Practice Solutions business, led by its current management team.
Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, Henry Schein, Inc. said: "RxWorks has an excellent reputation for helping veterinarians increase practice efficiency and improve quality health care through its innovative practice management software solutions.
"The addition of RxWorks further strengthens our growing practice management software solutions business, which helps deepen relationships in the regions served by RxWorks with our animal health customers, including large corporate customers. The addition of RxWorks will nicely complement our expanding animal health technology businesses. We look forward to welcoming our new colleagues from RxWorks to Henry Schein."
Nathan Basha, Chairman of RxWorks said: "RxWorks software is designed to facilitate consistency of patient care, enable practice growth, achieve enhanced profitability and optimize professional time, all the while improving the quality of life for patients. Aligning with Henry Schein, a global company committed to serving animal health professionals and bringing innovation to the marketplace, allows RxWorks to provide even further value to customers while expanding industry reach."
Henry Schein says it expects the acquisition to close in the second half of January 2016. Financial details and terms of the transaction were not disclosed.
The WSAVA has announced that its Animal Wellness and Welfare Committee (AWWC) has launched two new online training modules designed to provide veterinary professionals with a solid grounding in contemporary animal welfare issues.
Developed as a resource for everyday clinical use, they are intended to enable veterinary professionals around the world to expand their role as advocates for animals.
The two one-hour modules are based on materials developed by WSAVA partner, World Animal Protection in its Advanced Concepts in Animal Welfare educational resource.
The first module addresses contemporary animal welfare science and ethics and the understandings and definitions of animal welfare.
The second has a more clinical focus, covering aspects of animal welfare in practice, including behavioral and end of life issues. Both modules are now available for free download at http://tinyurl.com/hfs6s3s.
Dr Shane Ryan, co-chair of the AWWC, said: "We acknowledge the vital support of World Animal Protection and AWWC sponsor WALTHAM, as well as the WSAVA’s Friends of Animal Welfare donors for their generous support of this important work."
Pets At Home Vet Group and Dick White Referrals have announced a strategic partnership in order to develop Pets at Home's strategy for providing specialist care.
Pets at Home says it is creating a new divisional structure comprised of the existing First Opinion Division (Vets4Pets and Companion Care joint venture practices) and the new Specialist Division, which comprises Dick White Referrals, Northwest Surgeons, Anderson Moores, and Eye Vet Referrals.
Dick White has been appointed Clinical Director of the new Specialist Division.
Dick will remain as a shareholder in Dick White Referrals. He and three of the Specialist clinicians - Giunio Bruto Cherubini, Federico Corletto and Rob Foale - will retain 24% of the practice.
Sally Hopson, CEO of Pets at Home Vet Group said: "We are delighted to have attracted a colleague of Dick White’s pedigree to join us, not only to help drive the future growth of Dick White Referrals, but also to play a key role in developing our Specialist Division. Professor White is a key figure in the development of the Specialist Veterinary segment; he has trained many of the leading Specialist veterinary practitioners. This is a tremendous step forward for the Vet Group. I’m also very pleased that Professor White and his colleagues have chosen to remain as equity partners in Dick White Referrals."
Dick said: "Forming this strategic partnership provides great opportunities for us to continue to develop Dick White Referrals as a world class referrals centre with a team of leading Veterinary Specialists. I am delighted to be working with a partner that shares our vision for Dick White Referrals and is committed to supporting its future development. Joining the Board of the Specialist Division will allow me to provide clinical leadership and governance across the division, input into the formulation of strategy and support M&A activity and veterinary recruitment."
Dechra Veterinary Products has launched two new antibiotics with a new tablet technology designed to encourage more responsible use of antibiotics in practice.
Metrobactin is the first veterinary licensed metronidazole tablet for the treatment of anaerobic infections in dogs and cats. Amoxibactin is the only flavoured, double-divisible amoxicillin tablet for the treatment of urinary, reproductive and airway infections in dogs and cats.
Metrobactin and Amoxibactin are presented in 'SmartTab' double divisible tablets which can easily be divided into equal halves or quarters to ensure accurate dosing and to avoid the risk of antibiotic resistance associated with under dosing. The tablets are meat flavoured to encourage animals to accept them, thereby helping to ensure the full course is completed. There are also multiple dose strengths per product.
Dechra says it hopes these features will help vets engage with responsible antimicrobial stewardship.
Larry King, Marketing Manager UK & Ireland, said: "Dechra is acutely aware of the importance of using antibiotics responsibly and we appreciate that antibiotics are an important but complex area of veterinary medicine.
"Each case should be judged on its merits and considered use of antibiotics should be the practice, rather than using antibiotics as a precaution. Dechra suggests that antimicrobials are only used when an infection has been documented and, if possible, choices made on the results of culture and sensitivity testing and/or cytology testing. We encourage clinicians to consider other treatment options before using systemic antibiotics, for example, cases of surface pyoderma can receive topical treatment.
"Using narrower spectrum antibiotics reduces the selection pressure for resistance in commensal bacteria and if antibiotics are not resolving an infection, the diagnosis may be incorrect or there may be an underlying disease process."
He added: "The launch of Metrobactin and Amoxibactin will support our existing Clavudale antibiotic that combines amoxicillin and clavulanic acid and is part of our commitment to improve the options for treatment and responsible management of antibiotics.
"SmartTab’s innovative features will play a large role in the effective and responsible use of antibiotics. Dechra will be progressively introducing further antibiotics featuring SmartTab technology to support practices when dispensing antibiotics."
For more information visit www.dechra.co.uk/responsible.
The founders of ioLight, Andrew Monk and Richard Williams, will be in attendance on the Bayer stand to answer questions about the new product.
James Crawford, Head of Marketing at Bayer, said: "Bayer is delighted to present the ioLight microscope on our stand at the London Vet Show 2016. The microscope provides fantastically clear images and is simple to use, showing off Bayer's products for all our customers to see."
Professor Mike Taylor, a Diplomate of the European Veterinary Parasitology College, is in the process of evaluating the ioLight microscope as a tool for the diagnosis of parasitic infections of farm animals.
Normally he uses a laboratory microscope for this work but they are not routinely used on a farm. He has also tried a portable digital microscope, but finds it does not give the resolution required for identification of protozoan parasite species or for counting nematode eggs. Mike said: "The ioLight’s portability, image quality and connectivity to the Apple iPad offer great potential for the development of rapid methods for identifying parasites, or determining parasite burdens. I can envisage its use by both veterinarians and suitably trained livestock farmers, in the practice laboratory or directly on the farm."
Andrew Monk said: "Since our launch earlier this year we have seen a massive interest from the veterinary sector. We are thrilled to have the opportunity to demonstrate our microscope to such a large audience, and are looking forward to working with Bayer."
For more information visit iolight.co.uk or email Andrew Monk at andrew.monk@iolight.co.uk.
CM Research has announced the results of a survey conducted this month in which veterinary surgeons named Osurnia as the best new product of 2015.
290 companion animal veterinary surgeons took part in the survey, which is designed to provide veterinary surgeons with their peers’ unbiased judgement on which new veterinary products, services or devices have made the biggest impact on the industry.
The questions were unprompted to ensure that the respondents were not influenced by pre-set survey options. CM Research points to the fact that many of the products that featured in its rankings were launched before 2015, including 2nd and 3rd placed Apoquel and Bravecto, as evidence of this freedom.
The full list of products named more than once in this year's survey was:
Product
Manufacturer
Number of mentions
% of mentions
Osurnia
Elanco
67
23%
Apoquel
Zoetis
58
20%
Bravecto
MSD
29
10%
Semintra
Boehringer Ingelheim (BI)
13
4%
Amodip
Ceva
10
3%
Nexgard Spectra
Merial
8
Broadline
6
2%
UpCard
Vetoquinol
Zodon
5
Metabolic Diet
Hill's
4
1%
Nexgard
SDMA Test
IDEXX
Comfortis
3
Remend
Bayer
Seresto
Yumove
Lintbells
Bovela
BI
2
Comfortan
Dechra
Hill's y/d diet
Nutraquin
Nutravet
Pexion
Prinovox
Virbac
Pronefra
Thiafeline
Animalcare
Veraflox
Vetigel
Suneris
Cardalis
Hosted by Jo Hinde RVN (pictured right) and Ivan Crotaz MRCVS, the discussion makes use of the 'Claim CPD' feature on VetNurse.co.uk, through which you can claim time spent participating in or reading qualifying forum discussions on the site towards your annual CPD requirement.
Any forum discussion from which you learn something relevant to your job can be logged on the system, regardless of whether you contribute to the discussion or not, though obviously you can claim more time and have a better record if you join in. Just press the 'Claim CPD' button at the top right of the forum discussion thread. And if you come back to the same discussion and spend more time on it later, you can add more time to the record.
VetNurse Editor Arlo Guthrie said: "I hope you'll all get stuck in and make the most of this opportunity to throw your questions at Jo. She's been teaching rabbit husbandry and nursing to owners and nurses directly and also via the Rabbit Welfare Association since 2012, so she's a mine of information!"
Join the discussion, and claim your CPD here.
Bayer Animal Health has launched Remend Wound Spray Gel for cats, dogs and horses.
The new gel contains Remend's structurally modified hyaluronic acid (HA). Bayer says it provides a matrix for cellular events that occur during the proliferative phase of the healing process, which has been shown to enhance healing1, and can promote rapid wound closure
Georgie Hollis BSc from www.vetwoundlibrary.com said: "Managing wounds can be challenging in veterinary practice; the progression of wound healing can be influenced by many factors, and selecting an appropriate product to apply should be based on the needs of the individual wound. A product that provides a moist healing environment and support of the proliferative phase ensures that cellular activity is optimised, helping to improve healing times and minimise scar tissue."
Bayer says Remend Wound Spray Gel is designed for use as part of the overall management of wounds; additional measures such as lavage, debridement and control of infection are equally important, as is giving consideration to any secondary factors that may delay healing if not addressed. The product aims to achieve greater compliance amongst owners by providing an effective management option that is easy to apply. A single application may be sufficient to enhance wound closure in fresh uncomplicated wounds; however more complex wounds may require multiple applications in order to accelerate closure.
For more information, visit: www.vetcentre.bayer.co.uk
References
Abbeydale says this was a particularly special achievement because it was its first full inspection as a training provider.
Sam Morgan RVN, a director alongside Kirsty Gwynne RVN, said: "The inspectors were particularly impressed by our ambitious curriculum which reflects current industry practice, our ability to link on and off-the-job training, and how senior leaders and tutors support apprentices to understand career pathways.
“We are proud that our hard work has been recognised in this way.
"It is a team effort here at Abbeydale and it is a combination of all our tutors, learners, employers, clinical coaches, and governance boards’ input to ensure our provision is fit for purpose.”
The full Ofsted report can be read at www.reports.ofsted.gov.uk
To find out more about Abbeydale Vet Nurse Training visit www.vetnursetraining.co.uk
Photo: R-L Kirsty Gwynne RVN and Sam Morgan RVN.
Academics from the University of Bristol's School of Veterinary Sciences and the neurology team at Southmead Hospital Bristol have published the results of study examining the use of percutaneous electrical nerve stimulation (PENS) therapy as a treatment for headshaking syndrome in horses.
The authors say that the condition, a neuropathic facial pain syndrome, often leaves affected horses impossible to ride and dangerous to handle, and can result in euthanasia. At present there are no consistently safe and effective methods for the treatment of headshaking in horses, and the condition is estimated to affect between 10,000 and 20,000 horses in the UK.
The study, which is published in the Equine Veterinary Journal (EVJ), aimed to discover whether PENS therapy, developed by Algotec Research and Development Ltd, is safe, effective and sustainable for the management of trigeminal-mediated headshaking in horses.
Seven horses diagnosed with trigeminal-mediated headshaking were recruited to the trial. All procedures were carried out in sedated horses with a needle-*** sized area of skin desensitised with local anaesthetic to help probe insertion. A disposable PENS probe was placed just beneath the skin adjacent to the nerve under ultrasonographic guidance. The nerve was stimulated for 25 minutes following a protocol of alternating frequencies and a perception threshold based on human clinical data. The probe was removed and the procedure repeated on the other side. Three or four treatments were used during the protocol, with treatments being repeated when signs of headshaking recurred.
All horses tolerated the procedure well. Three horses developed a haematoma at the site on one occasion and two had increased clinical signs for up to three days following first treatment. Six horses responded well after the first treatment and returned to ridden work at the same level before headshaking began. Five horses continued to respond to further treatment.
Veronica Roberts, Senior Clinical Fellow in Equine Medicine in the University's School of Veterinary Sciences, who led the study, said: "Headshaking in horses is a major welfare issue and can be a significant cause of distress.
"Although it is clear that further work is required, including increasing the number of cases and refining the treatment procedures, the study shows that PENS therapy should be the first-line treatment for trigeminal-mediated headshakers, which have failed to respond to conservative treatment, such as nose-nets."
Dechra Veterinary Products has launched a new 50 ml bottle of its rapid acting dissociative anaesthetic licensed for cats, dogs and horses, Anesketin.
Anesketin solution for injection, containing Ketamine 100 mg/ml, is indicated for induction of anaesthesia.
Dechra Brand Manager Craig Sankey said: "Anesketin has proved to be a very popular product in our range due to its versatility. It can be used in combination with appropriate sedatives and analgesics in cats, dogs and horses for induction of anaesthesia.
"As it does not require any special temperature storage conditions it makes it a very portable product for vets on the move."
He added: "We are very pleased to be able to add the larger Anesketin product to our wide range of analgesics and sedatives. This demonstrates our commitment to offering high quality products that support vets in small animal and equine practice."
Dechra says the product can also be used as a sole agent for restraint and minor surgical procedures where muscle relaxation is not required in cats.
Anesketin is also available in 10 ml vials. For further information, visit www.dechra.co.uk
Ceva Animal Health has launched a new broad-spectrum, flavoured endoparasiticide tablet, Milbactor for dogs.
Milbactor contains milbemycin oxime and praziquantel, which offer protection against the common nematodes seen in the UK and the main species of tapeworm.
Milbemycin oxime treats Toxocara canis and Toxascaris leonina, Angiostrongylus vasorum and Crenosoma vulpis, the hookworm Ancylostoma caninum, the whipworm Trichuris vulpis and the eyeworm, Thelazia callipaeda. Milbactor also prevents heartworm disease caused by Dirofilaria immitis.
Praziquantel protects against Echinococcus spp., Dipylidium caninum,Taenia spp. and Mesocestoides spp.
Puppies weighing more than 0.5 kg can be treated with Milbactor from two weeks of age. Milbactor comes in two tablet sizes for dogs and puppies, and the tablets are flavoured for easy administration.
Ceva has also launched The Ceva Protection System for dogs, a two-step solution featuring Vectra 3D and Milbactor to provide ectoparasite and endoparasite protection for dogs with one monthly topical treatment and one flavoured tablet. The Ceva Protection System uses Vectra Felis for flea protection for cats and Acclaim for the treatment of the pet's home environment.
Rob McLintock MRCVS, companion animal business unit manager at Ceva Animal Health, said: "The launch of Milbactor and The Ceva Protection System will enable veterinary surgeons to offer their clients a simple regime featuring Vectra 3D and Milbactor for comprehensive parasite control in dogs. Offering protection both inside and out and with no bite required to kill fleas, the regime offers a simple, effective combination to treat and prevent fleas, ticks, biting flies, roundworms, tapeworms, lungworms and to prevent heartworm.
For further information on The Ceva Protection System, Milbactor, Vectra 3D or Vectra Felis, contact your local Ceva territory manager or call 01494 781510.
MSD Animal Health has announced the launch of The Big Tick Project, both to investigate whether ticks are carrying more pathogens and to raise awareness amongst the public.
The company highlights research which shows that nationally, tick distribution has expanded by 17% in the last 10 years and tick numbers have also increased in 73% of locations surveyed.1 In addition, the company says there is evidence that ticks are feeding earlier in the year and feeding for longer2, thus increasing their potential to pass on significant disease to both animals and humans. Lyme disease in particular can be serious health issue for both humans and animals, being increasingly recognised and recorded in the UK recent years3.
So, as part of the project, practices are being invited to collect ticks and send them to the University of Bristol for analysis. In addition, there'll be a national PR and marketing campaign fronted by the naturalist Chris Packham (pictured right).
Practices taking part in the project will receive a tick collection kit and marketing support pack including access to dedicated PR services, postcards and posters to raise awareness of ticks within their clinic and local community. The collection kit includes instructions, collection equipment and Freepost packaging to allow ticks removed from dogs to be sent to the university quickly and easily.
Professor Richard Wall from University of Bristol said: "For accurate results we need as many ticks as possible and I really encourage vet practices up and down the country to get involved. We need data from all types of practices ranging from urban to rural locations to help vets and human health professionals make more effective recommendations and help prevent tick-related disease."
To take part in The Big Tick Project, email a contact name and your practice details to: info@bigtickproject.co.uk.
The British Equine Veterinary Association has published the results of a survey it commissioned which found that horse vets in the UK are probably at greater risk of injury than any other civilian profession, including the prison service.
For the study, which was conducted by the Institute of Health and Wellbeing and the School of Veterinary Medicine at the University of Glasgow, 620 equine vets completed a work-related injuries questionnaire. The results of the study indicated that an equine vet could expect to sustain between seven and eight work-related injuries that impeded them from practicing, during a 30-year working life.
If the 620 respondents were representative of the rest of the profession, the injuries they reported would equate to 26,452 per 100,000 equine vets in employment per year. That compares with 10,760 for people working in the prison service, 8,700 for policemen below the rank of sergeant, 6,980 for welders, metal formers and related trades, and 4,760 for construction workers.
Participants were asked to describe their worst-ever injury. Most were described as bruising, fracture and laceration, with the most common site of injury being the leg (29%), followed by the head (23%). The main cause of injury was a kick with a hind limb (49%), followed by strike with a fore limb (11%), followed by crush injury (5%). Nearly a quarter of these reported injuries required hospital admission and notably, 7% resulted in loss of consciousness. The most common reason for the examination during which the injury occurred was foot lameness, followed by dental and female reproductive.
BEVA Past-President Keith Chandler said: “We were shocked to discover the extent of the injuries sustained. Of greatest concern is the number of vets who suffered head injuries and unconsciousness. These injuries appeared to be more common when certain procedures were being performed, such as endoscopy of the upper respiratory tract, when vets are often only partly sighted while using examination equipment, or during wound management and bandage-changes, where vets are often crouched-down for long periods, next to the patient.”
38% of the ‘worst’ injuries occurred when the vet was working with a ‘pleasure’ horse and most frequently (48% of all responses) the horse handler was the owner or the client at the time of the injury. Whilst the number of laypersons or handlers injured at the same time was low, Tim Parkin, vet and lead researcher, pointed out: “This work should act as a wake up call to all involved in the training, employment and engagement of equine vets. The risks associated with handling and working with horses should be the primary consideration for equine vets and horses owners alike, every time a horse is examined or treated. In addition, the experience of the horse handler should be considered when undertaking riskier procedures.”
David Mountford, Chief Executive of BEVA said: “The results are very concerning and justify a careful prospective scientific quantification of the risks. In the short term, knowledge of these risks allows us to better inform all vets who work with horses. In turn vets will be able to inform horse owners, horse-keepers and trainers of the risks, and this may provide justification for having trained assistance on-hand or the more extensive use of sedative drugs in practice, potentially reducing the risk of injury.
"The British Equine Veterinary Association will now look to work with the Health and Safety Executive, Veterinary Schools, large employers of vets in the UK and our members to help develop policies to mitigate the risk of serious injury for vets working with horses.”
Photograph courtesy Towcester Veterinary Centre
Virbac has has announced the launch of Buprevet, a buprenorphine-based, injectable solution indicated for the potentiation of sedative effects of centrally-acting agents in dogs and for use in cats and dogs as part of a multimodal approach to analgesia.
Buprevet is presented in a 10 ml multi-dose bottle which can be broached up to 25 times and can be open for up to 28 days.
Sarah Walker MRCVS, Product Manager, said: "Buprenorphine is a potent, high affinity, synthetic opioid agonist which forms a key element of practice anaesthetic protocols and complements our existing anaesthetic range. Its potentiation effects means less sedation is needed in the pre-medication and in the anaesthesia, facilitating smoother recoveries with more comfortable patients."
"Buprenorphine is a tried and trusted solution for analgesia in many practices. Buprevet can be given pre-operatively to allow analgesia during and after surgery. It works effectively as part of a pre-emptive approach to analgesia, alongside products such as Inflacam and Carprox in our NSAIDs range."
The Society of Practising Veterinary Surgeons (SPVS) reports that its annual Congress, held jointly with theVeterinary Practice Managers Association (VPMA) at the Celtic Manor Resort in Newport last week, was a sell out.
Over 470 delegates attended, of which 40% were practice owners, 40% were vets, 30% were practice managers and 10% were nurses.
Held over two days, the line-up of speakers included TV presenter, expedition leader, leadership trainer and ex-Royal Marine, Monty Halls who opened Congress with a talk on the importance of pushing your own personal boundaries. Psychiatrist, broadcaster and journalist, Dr Max Pemberton presented a guide to mental health problems for vets and managers. Celtic Manor’s head of 5 Star Service Delivery, Michael Pagnotta, explained how they ensure all their staff operate to the same consistently high level of service provision and Ian McKelvie, CEO of US consultancy, Becauz, presented a number of leadership and management sessions.
VetNurse.co.uk visited the commercial exhibition and ask a random selection of exhibitors: "What's New?"
This is what they said:
Royal Canin has announced that it has established a team of three specialist advisors to work directly with veterinary practices to help develop and improve their weight management clinics, client retention and product sales.
The Pet Weight Care Team will also provide practical training to all practice staff on how to recognise weight problems, communicate sensitively with pet owners and treat the problem effectively.
The first advisor to join the team is Shelley Holden VN (pictured right), who has 10 years' experience as the nurse for the Royal Canin Weight Management Referral Clinic at The University of Liverpool. Shelley has spent time running successful nursing clinics in general practice and lecturing internationally on the topic of obesity. She said: "I have spent many years dedicating my time caring for overweight pets, and the number of cases we see is continuing to rise. It's really important that as obesity specialists we can offer hands-on support to practices to assist them with helping to decrease the number of overweight pets they see.
"Our aim will be to offer specialist training through a number of sessions to practices who wish to improve their weight management clinics. We'll spend time with all members of staff helping them to feel more confident when dealing with owners who have overweight pets. The training will include all aspects of weight management including how to approach owners, Body Condition Scoring and the 30 minute consult. Staff will also be trained on how to support owners throughout the weight loss program and during the maintenance phase."
Royal Canin says the training will also cover the prevention of obesity in pets, how to advise owners on the appropriate diets post neutering and how to manage the animal's weight and calorie intake throughout their lives. The Pet Weight Care Team will be encouraging practices to carry out weight management assessments alongside medical examinations to ensure that potential weight problems are dealt with quickly.
The company says that practices that receive training will be followed up with on a regular basis to provide further support and training as needed.
For more information, contact your Royal Canin Veterinary Business Manager.